Varghese P, Kishore U, Rajkumari R
Int J Mol Sci. 2022; 23(6).
PMID: 35328462
PMC: 8949502.
DOI: 10.3390/ijms23063045.
Tang X, Ma X, Cao J, Sheng X, Xing J, Chi H
Front Immunol. 2022; 13:802638.
PMID: 35197977
PMC: 8858815.
DOI: 10.3389/fimmu.2022.802638.
Yilmaz I, Ipekoglu E, Bulbul A, Turay N, Yildirim M, Evcili I
Allergy. 2021; 77(1):258-270.
PMID: 34519053
PMC: 8653174.
DOI: 10.1111/all.15091.
Murugaiah V, Varghese P, Beirag N, De Cordova S, Sim R, Kishore U
Viruses. 2021; 13(5).
PMID: 34063241
PMC: 8147407.
DOI: 10.3390/v13050824.
Kurtovic L, Boyle M, Opi D, Kennedy A, Tham W, Reiling L
Immunol Rev. 2019; 293(1):38-56.
PMID: 31556468
PMC: 6972673.
DOI: 10.1111/imr.12802.
Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.
Lee S, Chu K, Kang H, Quan F
PLoS One. 2019; 14(8):e0220865.
PMID: 31465461
PMC: 6715270.
DOI: 10.1371/journal.pone.0220865.
Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.
Altman M, Angeletti D, Yewdell J
Viral Immunol. 2018; 31(2):142-149.
PMID: 29356618
PMC: 5863095.
DOI: 10.1089/vim.2017.0129.
Tackling influenza with broadly neutralizing antibodies.
Corti D, Cameroni E, Guarino B, Kallewaard N, Zhu Q, Lanzavecchia A
Curr Opin Virol. 2017; 24:60-69.
PMID: 28527859
PMC: 7102826.
DOI: 10.1016/j.coviro.2017.03.002.
Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim M, Lee J, Choi H, Lee Y, Hwang H, Lee J
J Control Release. 2015; 210:208-16.
PMID: 26003039
PMC: 4489561.
DOI: 10.1016/j.jconrel.2015.05.278.
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M, Keck Z, Rainey G, Lam C, Boon A, Rubrum A
J Virol. 2015; 89(8):4549-61.
PMID: 25673719
PMC: 4442345.
DOI: 10.1128/JVI.00078-15.
A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.
Pierson T, Diamond M
Prog Mol Biol Transl Sci. 2015; 129:141-66.
PMID: 25595803
PMC: 4910618.
DOI: 10.1016/bs.pmbts.2014.10.005.
Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
Oshansky C, Wong S, Jeevan T, Smallwood H, Webby R, Shafir S
mBio. 2014; 5(6):e02107.
PMID: 25491354
PMC: 4324241.
DOI: 10.1128/mBio.02107-14.
Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.
Kim M, Lee Y, Hwang H, Lee Y, Ko E, Jung Y
Vaccine. 2014; 32(44):5824-31.
PMID: 25171841
PMC: 4177275.
DOI: 10.1016/j.vaccine.2014.08.030.
Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.
Wolf A, Strauman M, Mozdzanowska K, Whittle J, Williams K, Sharpe A
J Virol. 2014; 88(20):11995-2005.
PMID: 25100838
PMC: 4178749.
DOI: 10.1128/JVI.01833-14.
Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.
Marinho C, Azeredo E, Torrentes-Carvalho A, Marins-Dos-Santos A, Kubelka C, de Souza L
PLoS One. 2014; 9(7):e102014.
PMID: 25061945
PMC: 4111305.
DOI: 10.1371/journal.pone.0102014.
Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
Tong H, Lambert G, Li Y, Thurman J, Stahl G, Douthitt K
PLoS One. 2014; 9(4):e95160.
PMID: 24740152
PMC: 3989264.
DOI: 10.1371/journal.pone.0095160.
Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.
Kim M, Lee Y, Ko E, Lee J, Kwon Y, Hwang H
Mol Ther. 2014; 22(7):1364-1374.
PMID: 24590045
PMC: 4089011.
DOI: 10.1038/mt.2014.33.
Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.
Kim M, Song J, O E, Kwon Y, Lee Y, Compans R
Mol Ther. 2012; 21(2):485-92.
PMID: 23247101
PMC: 3594028.
DOI: 10.1038/mt.2012.246.
Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant.
Kathuria N, Kraynyak K, Carnathan D, Betts M, Weiner D, Kutzler M
Hum Vaccin Immunother. 2012; 8(11):1607-19.
PMID: 23151454
PMC: 3601135.
DOI: 10.4161/hv.22574.
Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, Wang W
Influenza Other Respir Viruses. 2012; 7(3):480-90.
PMID: 23122228
PMC: 5779835.
DOI: 10.1111/irv.12029.
